LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

Начало・Списък с акции・Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

37.3 -2

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

37.03

Максимум

38.34

Ключови измерители
By Trading Economics
Приходи	-20M -85M
Марж на печалбата	-867.293
Служители	316
EBITDA	-21M -94M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+42.71% upside

Дивиденти
By Dow Jones
Следващи печалби	11.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	327M 2.9B
Предишно отваряне	39.3
Предишно затваряне	37.3

Настроения в новините

By Acuity

50%

156 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

34.81 / 38.24 Подкрепа & съпротива

Xenon Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.09.2025 г., 23:37 ч. UTC

Горещи акции

Stocks to Watch: Oracle, Wearable Devices, GameStop

9.09.2025 г., 20:41 ч. UTC

Печалби

Oracle's Backlog Surges With Major Customer Deals in 1Q

9.09.2025 г., 20:30 ч. UTC

Печалби

GameStop 2Q Sales, Profit Rise

9.09.2025 г., 23:19 ч. UTC

Пазарно говорене

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9.09.2025 г., 21:35 ч. UTC

Печалби

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 21:32 ч. UTC

Печалби

Oracle's Backlog Swells With Big Customer Deals -- Update

9.09.2025 г., 21:02 ч. UTC

Придобивния, сливания и поглъщания

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.09.2025 г., 20:33 ч. UTC

Печалби

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9.09.2025 г., 20:26 ч. UTC

Печалби

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 20:23 ч. UTC

Печалби

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 20:12 ч. UTC

Печалби

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9.09.2025 г., 20:10 ч. UTC

Печалби

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9.09.2025 г., 20:10 ч. UTC

Печалби

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9.09.2025 г., 20:09 ч. UTC

Печалби

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9.09.2025 г., 20:09 ч. UTC

Печалби

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle 1Q Operating Income Was $4.3 B >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9.09.2025 г., 20:07 ч. UTC

Печалби

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9.09.2025 г., 20:06 ч. UTC

Печалби

Oracle 1Q Software Revenue $5.72B >ORCL

9.09.2025 г., 20:06 ч. UTC

Печалби

Synopsys 3Q Adj EPS $3.39 >SNPS

9.09.2025 г., 20:06 ч. UTC

Печалби

Oracle 1Q Cloud Revenue $7.19B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Rev $14.93B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q EPS $1.01 >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Synopsys 3Q EPS $1.50 >SNPS

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Services Revenue $1.35B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Adj EPS $1.47 >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Hardware Revenue $670M >ORCL

Сравнение с други в отрасъла

Ценова промяна

Xenon Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

42.71% нагоре

12-месечна прогноза

Среден 54.5 USD 42.71%

Висок 65 USD

Нисък 48 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Xenon Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Xenon Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

34.81 / 38.24Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Настроение

By Acuity

156 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.